Insiders · Profile

Wells David R.

Chief Financial Officer at ENDRA Life Sciences. Filing since 22 Aug 2019. CIK 0001480371

Company
Date
Role
Action
Shares
Amount
Of holding
6 Jan 2021
Chief Financial Officer
Sold, plan not stated
34,900
$31.41K
30.4%
5 Jan 2021
Chief Financial Officer
Sold, plan not stated
100
$90.00
0.1%
27 Sep 2019
Chief Financial Officer
Bought
10,000
$11.80K
100%
23 Aug 2019
Chief Financial Officer
Bought
5,000
$7.75K
100%
22 Aug 2019
Chief Financial Officer
Bought
5,000
$7.80K
opened
5 decisions on file.